Daratumumab-based combination therapies (DCT) in heavily-pretreated patients (pts) with relapsed and/or refractory multiple myeloma (RRMM).
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Arjun Lakshman, Jithma P. Abeykoon, Shaji Kumar, S.Vincent Rajkumar, Taxiarchis Kourelis, Francis Buadi, David Dingli, Martha Lacy, Wilson I. Gonsalves, Angela Dispenzieri, Robert A. Kyle, Yi Lin, Ronald S. Go, Rahma M. Warsame, Suzanne R. Hayman, Stephen Russell, Nelson Leung, Morie A. Gertz, Prashant Kapoor
Institution: Mayo Clinic
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2891157482